Standard
Co-Amorphous Drug Formulations in Numbers: Recent Advances in Co-Amorphous Drug Formulations with Focus on Co-Formability, Molar Ratio, Preparation Methods, Physical Stability, In Vitro and In Vivo Performance, and New Formulation Strategies. / Liu, Jingwen; Grohganz, Holger; Lobmann, Korbinian; Rades, Thomas; Hempel, Nele-Johanna.
In:
Pharmaceutics, Vol. 13, No. 3, 389, 2021.
Research output: Contribution to journal › Review › Research
Harvard
Liu, J
, Grohganz, H, Lobmann, K, Rades, T & Hempel, N-J 2021, '
Co-Amorphous Drug Formulations in Numbers: Recent Advances in Co-Amorphous Drug Formulations with Focus on Co-Formability, Molar Ratio, Preparation Methods, Physical Stability, In Vitro and In Vivo Performance, and New Formulation Strategies',
Pharmaceutics, vol. 13, no. 3, 389.
https://doi.org/10.3390/pharmaceutics13030389APA
Liu, J.
, Grohganz, H., Lobmann, K., Rades, T., & Hempel, N-J. (2021).
Co-Amorphous Drug Formulations in Numbers: Recent Advances in Co-Amorphous Drug Formulations with Focus on Co-Formability, Molar Ratio, Preparation Methods, Physical Stability, In Vitro and In Vivo Performance, and New Formulation Strategies.
Pharmaceutics,
13(3), [389].
https://doi.org/10.3390/pharmaceutics13030389Vancouver
Liu J
, Grohganz H, Lobmann K, Rades T, Hempel N-J.
Co-Amorphous Drug Formulations in Numbers: Recent Advances in Co-Amorphous Drug Formulations with Focus on Co-Formability, Molar Ratio, Preparation Methods, Physical Stability, In Vitro and In Vivo Performance, and New Formulation Strategies.
Pharmaceutics. 2021;13(3). 389.
https://doi.org/10.3390/pharmaceutics13030389Author
Liu, Jingwen ; Grohganz, Holger ; Lobmann, Korbinian ; Rades, Thomas ; Hempel, Nele-Johanna. / Co-Amorphous Drug Formulations in Numbers: Recent Advances in Co-Amorphous Drug Formulations with Focus on Co-Formability, Molar Ratio, Preparation Methods, Physical Stability, In Vitro and In Vivo Performance, and New Formulation Strategies. In: Pharmaceutics. 2021 ; Vol. 13, No. 3.
Bibtex
@article{a905f281192042e48bc3b149876ba083,
title = "Co-Amorphous Drug Formulations in Numbers: Recent Advances in Co-Amorphous Drug Formulations with Focus on Co-Formability, Molar Ratio, Preparation Methods, Physical Stability, In Vitro and In Vivo Performance, and New Formulation Strategies",
keywords = "co-amorphous, poorly water soluble drugs, solid dispersion, co-formability, in vivo studies, physical stability, molar ratio optimization",
author = "Jingwen Liu and Holger Grohganz and Korbinian Lobmann and Thomas Rades and Nele-Johanna Hempel",
year = "2021",
doi = "10.3390/pharmaceutics13030389",
language = "English",
volume = "13",
journal = "Pharmaceutics",
issn = "1999-4923",
publisher = "MDPI AG",
number = "3",
}
RIS
TY - JOUR
T1 - Co-Amorphous Drug Formulations in Numbers: Recent Advances in Co-Amorphous Drug Formulations with Focus on Co-Formability, Molar Ratio, Preparation Methods, Physical Stability, In Vitro and In Vivo Performance, and New Formulation Strategies
AU - Liu, Jingwen
AU - Grohganz, Holger
AU - Lobmann, Korbinian
AU - Rades, Thomas
AU - Hempel, Nele-Johanna
PY - 2021
Y1 - 2021
KW - co-amorphous
KW - poorly water soluble drugs
KW - solid dispersion
KW - co-formability
KW - in vivo studies
KW - physical stability
KW - molar ratio optimization
U2 - 10.3390/pharmaceutics13030389
DO - 10.3390/pharmaceutics13030389
M3 - Review
C2 - 33804159
VL - 13
JO - Pharmaceutics
JF - Pharmaceutics
SN - 1999-4923
IS - 3
M1 - 389
ER -
